Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies.

[1]  R. Pande,et al.  A randomized trial of iloprost in patients with intermittent claudication , 2008, Vascular medicine.

[2]  A. Leizorovicz,et al.  Oral Buflomedil in the Prevention of Cardiovascular Events in Patients With Peripheral Arterial Obstructive Disease: A Randomized, Placebo-Controlled, 4-Year Study , 2008, Circulation.

[3]  V. Fuster,et al.  Meta-analysis of small trials: proceed with caution. , 2008, Nature clinical practice. Nephrology.

[4]  J. Price,et al.  Lipid-lowering for peripheral arterial disease of the lower limb. , 2007, The Cochrane database of systematic reviews.

[5]  R. Donnelly,et al.  Medical therapy for intermittent claudication. , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[6]  D. Duprez.  Pharmacological interventions for peripheral artery disease , 2007, Expert opinion on pharmacotherapy.

[7]  L. Norgren,et al.  Inter-society consensus for the management of peripheral arterial disease. , 2007, International angiology : a journal of the International Union of Angiology.

[8]  Deepak L. Bhatt,et al.  One-year cardiovascular event rates in outpatients with atherothrombosis. , 2007, JAMA.

[9]  D. Mikhailidis,et al.  Cilostazol for peripheral arterial disease. , 2007, The Cochrane database of systematic reviews.

[10]  S. Money,et al.  Current Management of Peripheral Arterial Occlusive Disease , 2007, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[11]  L. Norgren,et al.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). , 2007, Journal of vascular surgery.

[12]  Ralf Degenhardt,et al.  Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial. , 2006, JAMA.

[13]  W. Hiatt,et al.  Masterclass series in peripheral arterial disease , 2006, Vascular medicine.

[14]  W. Aronow.  Lipid-lowering therapy in high-risk persons , 2006, Comprehensive therapy.

[15]  K. Amendt.  PGE1 and Other Prostaglandins in the Treatment of Intermittent Claudication: A Meta-analysis , 2005, Angiology.

[16]  D. Goldsmith,et al.  Naftidrofuryl: a review of its use in the treatment of intermittent claudication. , 2005, Drugs & aging.

[17]  J. Cooke,et al.  Randomized trial of AT-1015 for treatment of intermittent claudication. A novel 5-hydroxytryptamine antagonist with no evidence of efficacy , 2004, Vascular medicine.

[18]  Mark A. Creager,et al.  Cholesterol Reduction With Atorvastatin Improves Walking Distance in Patients With Peripheral Arterial Disease , 2003, Circulation.

[19]  S. Mondillo,et al.  Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease. , 2003, The American journal of medicine.

[20]  J. Price,et al.  Steroid sex hormones for lower limb atherosclerosis. , 2012, The Cochrane database of systematic reviews.

[21]  J. Ware,et al.  Effect of Cilostazol on Treadmill Walking, Community‐Based Walking Ability, and Health‐Related Quality of Life in Patients with Intermittent Claudication Due to Peripheral Arterial Disease: Meta‐Analysis of Six Randomized Controlled Trials , 2002, Journal of the American Geriatrics Society.

[22]  D. Strandness,et al.  Effect of Cilostazol in Patients with Intermittent Claudication: A Randomized, Double-Blind, Placebo-Controlled Study , 2002, Vascular and endovascular surgery.

[23]  J. Regensteiner,et al.  Current medical therapies for patients with peripheral arterial disease: a critical review. , 2002, The American journal of medicine.

[24]  E. Mohler,et al.  Effects of cilostazol on resting ankle pressures and exercise-induced ischemia in patients with intermittent claudication , 2001, Vascular medicine.

[25]  J. Illnait,et al.  A Long-Term Study of Policosanol in the Treatment of Intermittent Claudication , 2001, Angiology.

[26]  T. D. de Backer,et al.  Oral vasoactive medication in intermittent claudication: utile or futile? , 2000, European Journal of Clinical Pharmacology.

[27]  J. Kleijnen,et al.  Vitamin E for intermittent claudication. , 1998, The Cochrane database of systematic reviews.

[28]  J. Kleijnen,et al.  Garlic for peripheral arterial occlusive disease. , 2000, The Cochrane database of systematic reviews.

[29]  K. Jaeger,et al.  Reliability of treadmill testing in peripheral arterial disease: a comparison of a constant load with a graded load treadmill protocol , 1999, Vascular medicine.

[30]  M. Prins,et al.  Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis. , 1999, Archives of internal medicine.

[31]  H. Tikkanen,et al.  Poor reproducibility of exercise test in assessment of claudication. , 1998, Clinical physiology.

[32]  J. A. Herd,et al.  Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease. , 1998, Journal of vascular surgery.

[33]  D. Moher,et al.  Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials. , 1996, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[34]  A R Jadad,et al.  Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.

[35]  S. Leveson,et al.  Double-blind, controlled, multicenter study of indobufen versus placebo in patients with intermittent claudication. , 1993, International angiology : a journal of the International Union of Angiology.

[36]  W. Brockhaus,et al.  Treatment of patients with peripheral arterial occlusive disease Fontaine stage IV with intravenous iloprost and PGE1: a randomized open controlled study. , 1993, Prostaglandins, leukotrienes, and essential fatty acids.

[37]  R. Jelnes,et al.  EDTA treatment of intermittent claudication — a doubleblind, placebo‐controlled study , 1992, Journal of internal medicine.

[38]  B. Berglund,et al.  Reproducibility of treadmill exercise in patients with intermittent claudication. , 1981, Clinical physiology.